Myelodysplastic syndrome - lenalidomide - initial or first continuing authority application form (PB012)

Use this form to apply for initial or first continuing PBS-subsidised treatment with lenalidomide for myelodysplastic syndrome.

Page last updated: 1 June 2025.
QC 20411